Navigation Links
Eye Diseases Diagnosed Through Genetical Testing

Researchers from the University of Michigan Kellogg Eye Center had developed a rapid genetical testing to diagnose eye diseases in people.

Scientists have created a first-of-its-kind test on a // microchip array that will help physicians hone their diagnoses for patients with the blinding disease known as retinitis pigmentosa (RP). The screening technique has proven to be reliable and cost-effective.

In the new issue of Investigative Ophthalmology & Visual Science (IOVS), scientists had reported on the arRP-I sequencing array, the first technology to screen simultaneously for mutations in multiple genes on a single platform.

A patient with the autosomal recessive form of the disease (arRP) has inherited one gene from each parent, neither of whom is affected by RP. It is nearly impossible to identify which form of the disease a patient has through a clinical examination alone.

Some clues to treatments are beginning to emerge in animal models, and scientists expect future therapies to be very specific to the type of RP.

The new study involved 70 individuals with a clinical diagnosis of arRP. Thirty-five had not been previously screened, and 35 others with known genetic mutations were screened to validate the results.

The arRP-I chip contained sequences, or genetic codes, of 11 genes that carry approximately 180 mutations associated with early-onset retinal degenerations. To date more than 30 genes have been identified for various forms of RP. Researchers note that while the size of the chip currently limit the ability to array all known RP genes, larger platforms are likely to be available soon.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. In Chronic Diseases - Poor compliance of Patients with drug treatment
2. ICMR along with other International Research organisation with drug development for Neglected Diseases
3. Chronic Diseases said to Cause Falls in the Elderly
4. Viagra Also Found To Be Effective For Treatment of Lung Diseases
5. The Drug Tetrathiomolybdate Found To Be Useful For Various Diseases
6. New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
7. New Diseases
8. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
9. Controlled Gene Expressions Can Cure Many Diseases
10. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
11. Digoxin Pill To Fight Against Both Heart Diseases And Cancer
Post Your Comments:
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
(Date:7/24/2008)...TON-SALEM, N.C. Researchers at Wake Forest Unive...-standing clinical belief that the hepatitis C vir...restore itself after HIV patients are treated with..., Hepatitis C (HCV) infection is more serious in...e, according to the Centers for Disease Control. I...
(Date:7/24/2008)...UTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 ... to report its 2008 second quarter and,year-to-dat...second quarter,and year-to-date financial results ...ding hours., The company will host a conference c...m. Eastern Time) on Tuesday, July 29, 2008. ev3,ma...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
... manufacturing computer chips. Now, the mega giant...thcare companies’ towards providing quality health...n others have joined hands to enable high-end heal...ntinua Health Alliance, led by Intel will seek to ...
...mputed tomography (CT), magnetic resonance imaging...he newly developed multi-modal contrast agent – Re...na-Champaign says. Use of these new agents may, i...sis and treatment of cancer, according to Kenneth ...
...he class X examination - a feat no girl of her vil...e, some 150 km from the state capital of Bhubanesw...mers. It does not have a school. Jharana Sahu use...ery day to study at a high school in nearby Kalupu...
... interact physically in a biochemical partnership ...ssels. // The study was conducted by researchers ...ne and Queen's University, Ontario, Canada and rep...dicine. The COX enzymes are well-known for their ...
Other Medicine News:Health News:New Multi-Modal Contrast Agents, A Boon For Medical Imaging 2Health News:New Multi-Modal Contrast Agents, A Boon For Medical Imaging 3Health News:New Multi-Modal Contrast Agents, A Boon For Medical Imaging 4Health News:New Role of COX Enzymes Discovered 2
(Date:7/22/2008)...s Including Lantus(R) and Apidra(R) Resulted in Si... 2 Diabetes, Whatever the Algorithm ...22 /- Results from the "Adjust to,Tar...orithm to Carbohydrate,Counting for Adjustment of ...in the American Diabetes Association,s (ADA) medic...
(Date:7/22/2008)... treatment with chemotherapy and pegylated enzyme ...ed to chemotherapy alone - - Pegy... /- Halozyme Therapeutics,... developing and,commercializing products targeting...sentation of positive pre-clinical animal efficacy...
(Date:7/22/2008)...IPOLIS, France, July 22 /- ...t has successfully completed the,enrollment of 417...rtension,in two clinical pharmacology studies in t...d timelines. These trials are designed to assess t...rison to ibuprofen and,naproxen, using the Ambulat...
(Date:7/21/2008)...ing to focus on use of Zevalin as consolidation th...reated patients with follicular ...re-FirstCall/ -- Cell Therapeutics, Inc.,(CTI) (Na...ny has scheduled,a meeting with the U.S. Food and ...the possibility of filing a supplemental Biologics...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4American Chemical Societys Weekly Presspac Sept 5 2007 853 1American Chemical Societys Weekly Presspac Sept 5 2007 853 2American Chemical Societys Weekly Presspac Sept 5 2007 853 3American Chemical Societys Weekly Presspac Sept 5 2007 853 4American Chemical Societys Weekly Presspac Sept 5 2007 853 5American Chemical Societys Weekly Presspac Sept 5 2007 853 6American Chemical Societys Weekly Presspac Sept 5 2007 853 7American Chemical Societys Weekly Presspac Sept 5 2007 853 8American Chemical Societys Weekly Presspac Sept 5 2007 853 9Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 1Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 2Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 1Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 2Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 1Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 2
...Closure of Multi-Center Trial in 4 Weeks Reinforce...s in Myeloma-, NORTH HOLLYWOOD, Calif., May 15, 20...ation (IMF) - supporting research and,providing ed...,families, researchers and physicians - today sai...enter myeloma trial using,REVLIMID(R) has demonstr...
... Poster Presented at Society for Investigative Der.../ -- AGI Dermatics,recently announced new comparat...cells have the ability to recognize, transport and...nst oxidative,damage, and importantly, that (EGT) ...than idebenone, scavenging reactive oxygen,species...
Other Medicine Technology:The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... into the body more easily than any comparable sco...ching the lower pole calyces. Its smooth, lubricio...on of both scope and instruments. And its patented...us tip, and active secondary deflection deliver co...
...Ureteroscope permits direct visualization and acce... little or no dilation.,A tight bend radius and ...renal access, including the lower pole calyces. Du...reter and the renal pelvis. The 6.75 beveled tip f...
Smooth, contoured standard obturator provides less traumatic insertion through the urethra and into the bladder.
Electrohydraulic Lithotripsy Probe for AEH-4
Medicine Products: